CAI — Caris Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual balance sheet for Caris Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	125	67.6	799
Net Total Accounts Receivable
Net Total Receivables	55.3	88.2	112
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	243	216	998
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	107	67.8	63.2
Net Goodwill
Other Long Term Assets
Total Assets	413	344	1,126
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	95.1	165	127
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	433	621	548
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-19.7	-277	577
Total Liabilities & Shareholders' Equity	413	344	1,126
Total Common Shares Outstanding